Literature DB >> 8744954

Biochemical toxicology of chemical teratogenesis.

P G Wells1, L M Winn.   

Abstract

Although exposure during pregnancy to many drugs and environmental chemicals is known to cause in utero death of the embryo of fetus, or initiate birth defects (teratogenesis) in the surviving offspring, surprisingly, little is known about the underlying biochemical and molecular mechanisms, or the determinants of teratological susceptibility, particularly in humans. In vitro and in vivo studies based primarily on rodent models suggest that many potential embryotoxic xenobiotics are actually proteratogens that must be bioactivated by enzymes such as the cytochromes P450 and peroxidases such as prostaglandin H synthase to teratogenic reactive intermediary metabolites. These reactive intermediates generally are electrophiles or free radicals that bind covalently (irreversibly) to, or directly of indirectly oxidize, embryonic cellular macromolecules such as DNA, protein, and lipid, irreversibly altering cellular function. Target oxidation, known as oxidase stress, often appears to be mediated by reactive oxygen species (ROS) such as hydroxyl radicals. The precise nature of the teratologically relevant molecular targets remains to be established, as do the relative conditions of the various types of macromolecular lesions. Teratological suseptibility appears to be determined in part by a balance among pathways of maternal xenobiotic elimination, embryonic xenobiotic bioactivation and detoxification of the xenobiotic reactive intermediate, direct and indirect pathways for the detoxification of ROS (cytoprotection), and repair of macromolecular lesions. Due largely to immature or otherwise compromised embryonic pathways for detoxification, Cytoprotection, and repair, the embryo is relatively susceptible to reactive intermediates, and teratogenesis via this mechanism can occur from exposure to therapeutic concentrations of drugs, or supposedly safe concentrations of environmental chemicals. Greater insight into the mechanisms involved in human reactive intermediate-mediated teratogenicity, and the determinants of individual teratological susceptibility, will be necessary to reduce the unwarranted embryonic attrition from xenobiotic exposure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8744954     DOI: 10.3109/10409239609110574

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  17 in total

Review 1.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

Review 2.  Teratogenic effects of thalidomide: molecular mechanisms.

Authors:  Takumi Ito; Hideki Ando; Hiroshi Handa
Journal:  Cell Mol Life Sci       Date:  2011-01-05       Impact factor: 9.261

Review 3.  Nrf2 and Nrf2-related proteins in development and developmental toxicity: Insights from studies in zebrafish (Danio rerio).

Authors:  Mark E Hahn; Alicia R Timme-Laragy; Sibel I Karchner; John J Stegeman
Journal:  Free Radic Biol Med       Date:  2015-06-28       Impact factor: 7.376

4.  Temporal and spatial expression of Hoxa-2 during murine palatogenesis.

Authors:  A Nazarali; R Puthucode; V Leung; L Wolf; Z Hao; J Yeung
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

5.  The Role of Redox Dysregulation in the Effects of Prenatal Stress on Embryonic Interneuron Migration.

Authors:  Jada Bittle; Edenia C Menezes; Michael L McCormick; Douglas R Spitz; Michael Dailey; Hanna E Stevens
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

6.  Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects.

Authors:  T I Chang; M Horal; S K Jain; F Wang; R Patel; M R Loeken
Journal:  Diabetologia       Date:  2003-03-26       Impact factor: 10.122

7.  Neurobehavioral manifestations of developmental impairment of the brain.

Authors:  Michal Dubovický
Journal:  Interdiscip Toxicol       Date:  2010-06

8.  Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits.

Authors:  Andrea W Wong; Gordon P McCallum; Winnie Jeng; Peter G Wells
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

9.  The transcription factor, Nuclear factor, erythroid 2 (Nfe2), is a regulator of the oxidative stress response during Danio rerio development.

Authors:  Larissa M Williams; Briony A Lago; Andrew G McArthur; Amogelang R Raphenya; Nicholas Pray; Nabil Saleem; Sophia Salas; Katherine Paulson; Roshni S Mangar; Yang Liu; Andy H Vo; Jordan A Shavit
Journal:  Aquat Toxicol       Date:  2016-10-01       Impact factor: 4.964

10.  A multi-center study for birth defect monitoring systems in Korea.

Authors:  Jae-Hyug Yang; Yon-Ju Kim; Jin-Hoon Chung; Moon-Young Kim; Hyun-Mee Ryu; Hyun-Kyong Ahn; Jung-Yul Han; Soon-Ha Yang; Ahm Kim; Hyun-Se Kim; Pyo-Jong Lee; Sung-Soo Kim; Young-Ju Kim; Kyung-Sim Koh; Jong-Chul Shin; Yong-Kun Cho; Bo-Hyun Yoon
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.